Address:
1275 York Ave, New York 10065
(212) 639-2530 (Phone)
Procedures:
Cardiac Myocardial Perfusion Imaging, Chest CT (incl. Heart and Lungs), Decortication and Pleurectomy, Lobectomy, Open, Lung Removal (Partial or Complete): Open, or Resection of Lung Tumor: Open, Lung Removal, Open, Lymph Node Biopsy or Excision, Open Thymectomy, Port Placements or Replacements, Segmentectomy, Open, Thoracoscopic Lobectomy, Thoracoscopic Segmentectomy, Thoracoscopic Wedge Resection, Tilt Testing or Cardiac Event Monitors, Tracheal Surgery, Video-Assisted Thoracic Surgery (VATS) or Thoracotomy
Conditions:
Aortic Valve Disease, Arrhythmias (incl. Atrial Fibrillation), Cardiomegaly, Cardiomyopathy, Carotid Artery Disease, Congestive Heart Failure, Coronary Artery Disease (CAD), Esophageal Cancer, Lung Cancer, Lung Neoplasms, Not Specified as Malignant, Mediastinal Tumors, Malignant, Mediastinal Tumors, Not Specified as Malignant, Mitral Valve Disease, Neuroendocrine Tumors, Pericardial Disease, Pleura Cancer, Pleural Neoplasm, Malignant, Pleural Neoplasm, Not Specified as Malignant, Pulmonary Embolism, Thymomas
Certifications:
General Surgery, 2006, Thoracic Cardiovascular Surgery, 2008
Hospitals:
1275 York Ave, New York 10065
Memorial Sloan - Kettering Cancer Center
1275 York Ave, New York 10065
Philosophy:
I am a surgeon who specializes in the treatment of cancers of the chest including lung cancer, esophageal cancer, thymoma, thymic carcinoma, mediastinal tumors, lung metastases, and mesothelioma. When possible, I utilize minimally invasive surgical techniques to reduce trauma and speed the recovery process. Video-assisted thoracic surgery (VATS) lobectomy permits the removal of lung tumors through small incisions, and endobronchial ultrasound (EBUS) now provides a much less invasive method to biopsy and stage lung cancer.
I have a special interest in the treatment of patients with thymoma, thymic carcinoma, and other mediastinal tumors. My research centers on increasing our knowledge about these uncommon diseases. By examining the genetic and molecular characteristics of thymomas and thymic carcinomas, we can better understand how these tumors develop and can create new targeted therapies to treat them. To enhance the quality of our care, I developed and maintain the MSKCC thymoma database to follow the outcomes of our patients. My colleagues and I are actively pursuing clinical trials to find more-effective therapies to treat these tumors. The treatment of these tumors often requires a collaborative effort between surgeons, oncologists and radiation oncologists, and we are fortunate here at MSKCC to have a team of experts specifically interested in thymoma and thymic carcinoma.
In addition, I am also committed to the training of future leaders in thoracic surgery. I lead the teaching program for our fellows in thoracic surgery and serve on a national committee overseeing all thoracic surgery training programs in the United States. The interaction we have with our fellows and students is a continual source of renewal and enrichment. Educating the physicians of tomorrow is a unique privilege that will continue to advance our fight against cancer.
Education:
Medical School
Columbia University College Of Physicians and Surgeons
Graduated: 1998
Brigham and Women's Hospital
New York Presbyterian Hospital/Weill Cornell Medical Center